Abbott Laboratories (ABT)
Market Open
8 Aug, 18:11
$
134. 56
+2.5
+1.89%
$
227.88B Market Cap
36.49 P/E Ratio
2.2% Div Yield
3,056,851 Volume
4.44 Eps
$ 132.06
Previous Close Day Range
131.75 134.74
Year Range
107.11 141.23
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days
Summary
ABT trading today higher at $134.56, an increase of 1.89% from yesterday's close, completing a monthly increase of 5.5% or $7.02. Over the past 12 months, ABT stock gained 18.36%.
ABT pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next announced payment will be in In 1 week on Aug 15, 2025 for a total of $0.59.
The last earnings report, released on Jul 17, 2025, exceeded the consensus estimates by 0.02%. On average, the company has fell short of earnings expectations by -0.41%, based on the last three reports. The next scheduled earnings report is due on Oct 14, 2025.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 15 different exchanges and in various currencies, with the primary listing on NYSE (USD).
ABT Chart
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks | 2 days ago
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
ABT's Diabetes Care sales surge 19.6% in Q2, fueled by strong U.S. demand and new OTC approvals for its CGM systems.
Zacks | 2 days ago
3 Dividend Growth Stocks That Will Deliver Meaty Returns After 5 Years
Sufficient earnings growth to continually increase dividends at a comfortably low payout ratio that also accommodates expansion capex is an excellent signal for strong upside potential.
247wallst | 1 week ago
Abbott Laboratories Dividends
| ABT 3 weeks ago Announced | Quarterly | $0.59 Per Share |
| ABT 3 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 6 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 9 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 15 Jul 2024 Paid | Quarterly | $0.55 Per Share |
Abbott Laboratories Earnings
| 15 Oct 2025 (In 2 months) Date | | 1.3 Cons. EPS | - EPS |
| 14 Oct 2025 (In 2 months) Date | | 1.34 Cons. EPS | - EPS |
| 17 Jul 2025 Date | | 0.99 Cons. EPS | 1.01 EPS |
| 16 Jul 2025 Date | | 1.25 Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| ABT 3 weeks ago Announced | Quarterly | $0.59 Per Share |
| ABT 3 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 6 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 9 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 15 Jul 2024 Paid | Quarterly | $0.55 Per Share |
| 15 Oct 2025 (In 2 months) Date | | 1.3 Cons. EPS | - EPS |
| 14 Oct 2025 (In 2 months) Date | | 1.34 Cons. EPS | - EPS |
| 17 Jul 2025 Date | | 0.99 Cons. EPS | 1.01 EPS |
| 16 Jul 2025 Date | | 1.25 Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
Abbott Laboratories (ABT) FAQ
What is the stock price today?
The current price is $134.56.
On which exchange is it traded?
Abbott Laboratories is listed on NYSE.
What is its stock symbol?
The ticker symbol is ABT.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.2%.
What is its market cap?
As of today, the market cap is 227.88B.
What is the earnings per share?
The EPS is 1.34.
When is the next earnings date?
The next earnings report will release on Oct 14, 2025.
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.
Abbott Laboratories Profile
| Medical - Devices Industry | Healthcare Sector | Robert B. Ford CEO | NYSE Exchange | 002824100 Cusip |
| US Country | 114,000 Employees | 15 Jul 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
2025 © Marketlog. All Rights Reserved.
